Ignite Creation Date:
2024-05-06 @ 4:48 PM
Last Modification Date:
2024-10-26 @ 2:16 PM
Study NCT ID:
NCT05097911
Status:
RECRUITING
Last Update Posted:
2021-10-28
First Post:
2021-08-31
Brief Title:
Phase I Study of RNA Oligonucleotide MTL-CEBPA Atezolizumab and Bevacizumab in Patients With Advanced Hepatocellular Carcinoma
Sponsor:
National University Hospital Singapore
Organization:
National University Hospital Singapore
Organization Data
Organization:
National University Hospital Singapore
Class:
OTHER
Study ID:
202000223
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
National University Hospital Singapore
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None